Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper generic copycats
Chris Selley: Canadian protectionism is on the march
- yesterday, 6:02 PM
- nationalpost.com
- 0

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper generic copycats
No comments